{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:05:25Z","timestamp":1790705125186,"version":"4.1.0"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T00:00:00Z","timestamp":1638057600000},"content-version":"vor","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004612","name":"Funda\u00e7\u00e3o Arauc\u00e1ria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004612","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.imlet.2020.11.009","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T11:20:28Z","timestamp":1606303228000},"page":"32-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Neuroimmune communication in infection and pain: Friends or foes?"],"prefix":"10.1016","volume":"229","author":[{"given":"Victor","family":"Fattori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila R.","family":"Ferraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda S.","family":"Rasquel-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Waldiceu A.","family":"Verri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cell.2009.09.028","article-title":"Cellular and molecular mechanisms of pain","volume":"139","author":"Basbaum","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2020.11.009_bib0010","first-page":"146","article-title":"Neuroimmune regulation of pain and inflammation: targeting glial cells and nociceptor sensory neurons interaction","volume":"3","author":"Fattori","year":"2017"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pharmthera.2006.04.001","article-title":"Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development?","volume":"112","author":"Verri","year":"2006","journal-title":"Pharmacol. Ther."},{"issue":"5472","key":"10.1016\/j.imlet.2020.11.009_bib0020","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1126\/science.288.5472.1765","article-title":"Neuronal plasticity: increasing the gain in pain","volume":"288","author":"Woolf","year":"2000","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","article-title":"Nociceptor sensory neuron-immune interactions in pain and inflammation","volume":"38","author":"Pinho-Ribeiro","year":"2017","journal-title":"Trends Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2020.11.009_bib0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1080\/14728222.2017.1398734","article-title":"Targeting IL-33\/ST2 signaling: regulation of immune function and analgesia","volume":"21","author":"Fattori","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"8","key":"10.1016\/j.imlet.2020.11.009_bib0035","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1084\/jem.20181657","article-title":"Cartilage-binding antibodies induce pain through immune complex-mediated activation of neurons","volume":"216","author":"Bersellini Farinotti","year":"2019","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0040","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cell.2018.04.006","article-title":"Blocking neuronal signaling to immune cells treats streptococcal invasive infection","volume":"173","author":"Pinho-Ribeiro","year":"2018","journal-title":"Cell"},{"issue":"7465","key":"10.1016\/j.imlet.2020.11.009_bib0045","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature12479","article-title":"Bacteria activate sensory neurons that modulate pain and inflammation","volume":"501","author":"Chiu","year":"2013","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.imlet.2020.11.009_bib0050","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1016\/j.celrep.2017.06.002","article-title":"Nociceptors boost the resolution of fungal osteoinflammation via the TRP Channel-CGRP-Jdp2 Axis","volume":"19","author":"Maruyama","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.imlet.2020.11.009_bib0055","article-title":"Gut-innervating nociceptor neurons regulate peyer\u2019s patch microfold cells anD. SFB levels to mediate salmonella host defense","author":"Lai","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.imlet.2020.11.009_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2016.12.023","article-title":"Bacterial signaling to the nervous system via toxins and metabolites","author":"Yang","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090013","article-title":"Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4\/MyD88-dependent cytokine cascade in the mice paw","volume":"9","author":"Calil","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0070","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pbb.2006.05.008","article-title":"Hypernociception elicited by tibio-tarsal joint flexion in mice: a novel experimental arthritis model for pharmacological screening","volume":"84","author":"Guerrero","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0075","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/jnr.1249","article-title":"PKC and PKA, but not PKG mediate LPS-induced CGRP release and [Ca(2+)](i) elevation in DRG neurons of neonatal rats","volume":"66","author":"Hou","year":"2001","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0080","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0022034511400225","article-title":"LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons","volume":"90","author":"Diogenes","year":"2011","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.imlet.2020.11.009_bib0085","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1038\/ncomms4125","article-title":"TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins","volume":"5","author":"Meseguer","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.imlet.2020.11.009_bib0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceca.2018.04.004","article-title":"Differential effects of lipopolysaccharide on mouse sensory TRP channels","volume":"73","author":"Boonen","year":"2018","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0095","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41467-017-02448-6","article-title":"Staphylococcus aureus produces pain through pore-forming toxins and neuronal TRPV1 that is silenced by QX-314","volume":"9","author":"Blake","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.cell.2020.02.026","article-title":"Mycobacterium tuberculosis Sulfolipid-1 activates nociceptive neurons and induces cough","volume":"181","author":"Ruhl","year":"2020","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0105","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2017.02.009","article-title":"An intestinal organ culture system uncovers a role for the nervous system in microbe-immune crosstalk","volume":"168","author":"Yissachar","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2011.10.023","article-title":"Toll-like receptor 2\/MyD88 signaling mediates zymosan-induced joint hypernociception in mice: participation of TNF-alpha, IL-1beta and CXCL1\/KC","volume":"674","author":"Guerrero","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0115","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajog.2015.02.002","article-title":"Identification of novel mechanisms involved in generating localized vulvodynia pain","volume":"213","author":"Falsetta","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.imlet.2020.11.009_bib0120","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.isci.2018.08.007","article-title":"The ATP transporter VNUT mediates induction of Dectin-1-Triggered Candida nociception","volume":"6","author":"Maruyama","year":"2018","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0125","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.immuni.2015.08.016","article-title":"Nociceptive sensory fibers drive Interleukin-23 production from CD301b+ dermal dendritic cells and drive protective cutaneous immunity","volume":"43","author":"Kashem","year":"2015","journal-title":"Immunity"},{"issue":"101","key":"10.1016\/j.imlet.2020.11.009_bib0130","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002613","article-title":"Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia","volume":"3","author":"Farmer","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.imlet.2020.11.009_bib0135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nrd1852","article-title":"Chemokines: integrators of pain and inflammation","volume":"4","author":"White","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0960-9822(06)00055-8","article-title":"CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons","volume":"7","author":"Hesselgesser","year":"1997","journal-title":"Curr. Biol."},{"issue":"24","key":"10.1016\/j.imlet.2020.11.009_bib0145","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1056\/NEJMoa030265","article-title":"Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection","volume":"349","author":"Shafer","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00002030-200002180-00009","article-title":"Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea","volume":"14","author":"Moore","year":"2000","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0155","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/aid.2011.0116","article-title":"Epidemiology of HIV-related neuropathy: a systematic literature review","volume":"28","author":"Ghosh","year":"2012","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0160","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ana.24139","article-title":"Gp120 in the pathogenesis of human immunodeficiency virus-associated pain","volume":"75","author":"Yuan","year":"2014","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0165","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0028-3908(03)00133-3","article-title":"Functional evidence for interaction between prostaglandin EP3 and kappa-opioid receptor pathways in tactile pain induced by human immunodeficiency virus type-1 (HIV-1) glycoprotein gp120","volume":"45","author":"Minami","year":"2003","journal-title":"Neuropharmacology"},{"issue":"14","key":"10.1016\/j.imlet.2020.11.009_bib0170","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1523\/JNEUROSCI.21-14-05027.2001","article-title":"Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons","volume":"21","author":"Oh","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.imlet.2020.11.009_bib0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainresbull.2017.01.002","article-title":"A317491 relieved HIV gp120-associated neuropathic pain involved in P2X3 receptor in dorsal root ganglia","volume":"130","author":"Yi","year":"2017","journal-title":"Brain Res. Bull."},{"issue":"Suppl 1","key":"10.1016\/j.imlet.2020.11.009_bib0180","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1386-6532(10)70003-2","article-title":"The impact of varicella zoster virus: chronic pain","volume":"48","author":"Opstelten","year":"2010","journal-title":"J. Clin. Virol."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s13365-017-0521-4","article-title":"HSV-1 interaction to 3-O-sulfated heparan sulfate in mouse-derived DRG explant and profiles of inflammatory markers during virus infection","volume":"23","author":"Sharthiya","year":"2017","journal-title":"J. Neurovirol."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0190","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/13550280590924214","article-title":"Nectin-1\/HveC mediates herpes simplex virus type 1 entry into primary human sensory neurons and fibroblasts","volume":"11","author":"Simpson","year":"2005","journal-title":"J. Neurovirol."},{"issue":"27","key":"10.1016\/j.imlet.2020.11.009_bib0195","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1523\/JNEUROSCI.2233-16.2017","article-title":"Neuroimmune-glia interactions in the sensory ganglia account for the development of acute herpetic neuralgia","volume":"37","author":"Silva","year":"2017","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005615","article-title":"Virus infections incite pain hypersensitivity by inducing indoleamine 2,3 dioxygenase","volume":"12","author":"Huang","year":"2016","journal-title":"PLoS Pathog."},{"issue":"18","key":"10.1016\/j.imlet.2020.11.009_bib0205","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1523\/JNEUROSCI.3055-19.2020","article-title":"Type I interferons act directly on nociceptors to produce pain sensitization: implications for viral infection-induced pain","volume":"40","author":"Barragan-Iglesias","year":"2020","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0210","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00436-016-5340-7","article-title":"Leishmania infection: painful or painless?","volume":"116","author":"Borghi","year":"2017","journal-title":"Parasitol. Res."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0215","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0304-3959(99)00297-3","article-title":"Hyperalgesia and upregulation of cytokines and nerve growth factor by cutaneous leishmaniasis in mice","volume":"85","author":"Kanaan","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.imlet.2020.11.009_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2017.02.009","article-title":"Leishmania (L). Amazonensis induces hyperalgesia in balb\/c mice: contribution of endogenous spinal cord TNFalpha and NFkappaB activation","volume":"268","author":"Borghi","year":"2017","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12974-019-1496-2","article-title":"Contribution of spinal cord glial cells to L. Amazonensis experimental infection-induced pain in BALB\/c mice","volume":"16","author":"Borghi","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0230","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00418-003-0532-5","article-title":"Effect of intestinal inflammation on capsaicin-sensitive afferents in the ileum of Schistosoma mansoni-infected mice","volume":"119","author":"De Jonge","year":"2003","journal-title":"Histochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0005-2760(94)90185-6","article-title":"Lipoxin biosynthesis and its impact in inflammatory and vascular events","volume":"1212","author":"Serhan","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.imlet.2020.11.009_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104549","article-title":"Specialized pro-resolving lipid mediators: a new class of non-immunosuppressive and non-opioid analgesic drugs","volume":"151","author":"Fattori","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.imlet.2020.11.009_bib0245","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mam.2017.03.005","article-title":"Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors","volume":"58","author":"Chiang","year":"2017","journal-title":"Mol. Aspects Med."},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0250","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1096\/fj.201601222R","article-title":"Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms","volume":"31","author":"Serhan","year":"2017","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0255","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.imlet.2020.11.009_bib0260","doi-asserted-by":"crossref","DOI":"10.1111\/bph.14647","article-title":"The specialized pro-resolving lipid mediator Maresin-1 reduces inflammatory pain with a long-lasting analgesic effect","author":"Fattori","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.imlet.2020.11.009_bib0265","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2020.11.009_bib0270","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.4049\/jimmunol.174.7.4345","article-title":"Molecular circuits of resolution: formation and actions of resolvins and protectins","volume":"174","author":"Bannenberg","year":"2005","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2020.11.009_bib0275","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1182\/blood-2007-12-129767","article-title":"Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP","volume":"112","author":"Bystrom","year":"2008","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.imlet.2020.11.009_bib0280","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1182\/blood-2011-04-345330","article-title":"Transcriptomic analyses of murine resolution-phase macrophages","volume":"118","author":"Stables","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.imlet.2020.11.009_bib0285","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1182\/blood-2014-03-562710","article-title":"Resolution of acute inflammation bridges the gap between innate and adaptive immunity","volume":"124","author":"Newson","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2020.11.009_bib0290","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fimmu.2012.00298","article-title":"Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation","volume":"3","author":"Recchiuti","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imlet.2020.11.009_bib0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2018.04.014","article-title":"Lipoxin A4 inhibits UV radiation-induced skin inflammation and oxidative stress in mice","author":"Martinez","year":"2018","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0300","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.pain.2010.11.021","article-title":"Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1","volume":"152","author":"Huang","year":"2011","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0305","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/2040622313485275","article-title":"Prevention of infection caused by immunosuppressive drugs in gastroenterology","volume":"4","author":"Orlicka","year":"2013","journal-title":"Ther. Adv. Chronic Dis."},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0310","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.rbr.2016.07.008","article-title":"Severe infection in patients with rheumatoid arthritis taking anakinra, rituximab, or abatacept: a systematic review of observational studies","volume":"56","author":"Cabral","year":"2016","journal-title":"Rev. Bras. Reumatol. Engl. Ed."},{"issue":"14","key":"10.1016\/j.imlet.2020.11.009_bib0315","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1111\/bph.13750","article-title":"Opioids and the immune system - friend or foe","volume":"175","author":"Plein","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0320","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2174\/157016212802138779","article-title":"Opiate drug use and the pathophysiology of neuroAIDS","volume":"10","author":"Hauser","year":"2012","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.imlet.2020.11.009_bib0325","first-page":"103","article-title":"Interactions of opioids and HIV infection in the pathogenesis of chronic pain","volume":"7","author":"Liu","year":"2016","journal-title":"Front. Microbiol."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0330","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.180.5.3594","article-title":"Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9-NF-kappa B signaling","volume":"180","author":"Wang","year":"2008","journal-title":"J. Immunol."},{"issue":"7395","key":"10.1016\/j.imlet.2020.11.009_bib0335","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0340","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/mi.2017.36","article-title":"Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection","volume":"11","author":"Codagnone","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"7268","key":"10.1016\/j.imlet.2020.11.009_bib0345","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","article-title":"Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis","volume":"461","author":"Spite","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2020.11.009_bib0350","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2309175","article-title":"Maresin1 alleviates metabolic dysfunction in septic mice: a (1)H NMR-Based metabolomics analysis","volume":"2019","author":"Hao","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0355","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41598-017-00103-0","article-title":"Protectin DX increases survival in a mouse model of sepsis by ameliorating inflammation and modulating macrophage phenotype","volume":"7","author":"Xia","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0360","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/IAI.01131-15","article-title":"Maresin 1 biosynthesis and proresolving anti-infective functions with human-localized aggressive periodontitis leukocytes","volume":"84","author":"Wang","year":"2015","journal-title":"Infect. Immun."},{"issue":"29","key":"10.1016\/j.imlet.2020.11.009_bib0365","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1073\/pnas.1605635113","article-title":"Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis","volume":"113","author":"Koopman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0370","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20132103","article-title":"Vagus nerve controls resolution and pro-resolving mediators of inflammation","volume":"211","author":"Mirakaj","year":"2014","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.imlet.2020.11.009_bib0375","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.4049\/jimmunol.1800806","article-title":"Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids","volume":"201","author":"Serhan","year":"2018","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0380","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2016.12.009","article-title":"Vagal regulation of group 3 innate lymphoid cells and the immunoresolvent PCTR1 controls infection resolution","volume":"46","author":"Dalli","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0385","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20081880","article-title":"Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions","volume":"206","author":"Serhan","year":"2009","journal-title":"J. Exp. Med."},{"issue":"50","key":"10.1016\/j.imlet.2020.11.009_bib0390","doi-asserted-by":"crossref","first-page":"18433","DOI":"10.1523\/JNEUROSCI.4192-11.2011","article-title":"Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1\/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1","volume":"31","author":"Park","year":"2011","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0395","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2123","article-title":"Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions","volume":"16","author":"Xu","year":"2010","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0400","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1476-5381.2011.01568.x","article-title":"17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception","volume":"165","author":"Bang","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.imlet.2020.11.009_bib0405","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","article-title":"Pain and immunity: implications for host defence","volume":"19","author":"Baral","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.11.009_bib0410","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2016.01.027","article-title":"Neutrophils and arthritis: Role in disease and pharmacological perspectives","volume":"112","author":"Fattori","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0415","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm.4501","article-title":"Nociceptor sensory neurons suppress neutrophil and \u03b3\u03b4 T cell responses in bacterial lung infections and lethal pneumonia","volume":"24","author":"Baral","year":"2018","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0420","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/01.shk.0000183395.29014.7c","article-title":"Calcitonin gene-related peptide inhibits local acute inflammation and protects mice against lethal endotoxemia","volume":"24","author":"Gomes","year":"2006","journal-title":"Shock"},{"issue":"8","key":"10.1016\/j.imlet.2020.11.009_bib0425","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.imbio.2012.04.009","article-title":"Deficiency of the CGRP receptor component RAMP1 attenuates immunosuppression during the early phase of septic peritonitis","volume":"217","author":"Jusek","year":"2012","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0430","article-title":"Neuropeptide substance P upregulates chemokine and chemokine receptor expression in primary mouse neutrophils","volume":"293","author":"Sun","year":"2007","journal-title":"Am. J. Phys. Cell Physiol."},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0435","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jlb.65.6.834","article-title":"Substance P primes the formation of hydrogen peroxide and nitric oxide in human neutrophils","volume":"65","author":"Sterner-Kock","year":"1999","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0440","first-page":"152","article-title":"Substance P increases neutrophil adhesion to bronchial epithelial cells","volume":"1994","author":"De Rose","year":"1950","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2020.11.009_bib0445","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0024-3205(02)01740-X","article-title":"Direct antimicrobial properties of substance P","volume":"71","author":"Kowalska","year":"2002","journal-title":"Life Sci."},{"issue":"3\u20134","key":"10.1016\/j.imlet.2020.11.009_bib0450","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.vetimm.2010.03.011","article-title":"Substance P alters the in vitro LPS responsiveness of bovine monocytes and blood-derived macrophages","volume":"136","author":"Sipka","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"issue":"12","key":"10.1016\/j.imlet.2020.11.009_bib0455","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1016\/j.ajpath.2016.08.014","article-title":"The role of substance P in pulmonary clearance of Bacteria in comparative injury models","volume":"186","author":"Hsieh","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0460","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.1601751","article-title":"Role of substance P neuropeptide in inflammation, wound healing, and tissue homeostasis","volume":"199","author":"Suvas","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.009_bib0465","first-page":"17","volume":"Vol. 62","author":"Chen","year":"2020"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-042718-041812","article-title":"Neuro\u2013immune cell units: a new paradigm in physiology","volume":"37","author":"Godinho-Silva","year":"2019","journal-title":"Annu. Rev. Immunol."},{"issue":"7465","key":"10.1016\/j.imlet.2020.11.009_bib0475","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nature12479","article-title":"Bacteria activate sensory neurons that modulate pain and inflammation","volume":"501","author":"Chiu","year":"2013","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.imlet.2020.11.009_bib0480","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1002\/eji.201444553","article-title":"Neuroimmunological communication via CGRP promotes the development of a regulatory phenotype in TLR4-stimulated macrophages","volume":"44","author":"Baliu-Piqu\u00e9","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0485","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jlb.61.2.216","article-title":"Regulation of cytokine expression in macrophages and the Langerhans cell-like line XS52 by calcitonin gene-related peptide","volume":"61","author":"Torii","year":"1997","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0490","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjp.0706198","article-title":"Expression of functional NK 1 receptors in human alveolar macrophages: superoxide anion production, cytokine release and involvement of NF-\u03ba\u03b2 pathway","volume":"145","author":"Bardelli","year":"2005","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0495","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0197-0186(01)00094-8","article-title":"Substance P and calcitonin gene-related peptide increase IL-1\u03b2, IL-6 and TNF\u03b1 secretion from human peripheral blood mononuclear cells","volume":"40","author":"Cuesta","year":"2002","journal-title":"Neurochem. Int."},{"issue":"4870","key":"10.1016\/j.imlet.2020.11.009_bib0500","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1126\/science.2457950","article-title":"Effect of neuropeptides on production of inflammatory cytokines by human monocytes","volume":"241","author":"Lotz","year":"1988","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0505","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/0006-291X(80)90581-1","article-title":"Enhancement of phagocytosis - A newly found activity of Substance P residing in its N-terminal tetrapeptide sequence","volume":"94","author":"Bar-Shavit","year":"1980","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0510","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1398-9995.1995.tb01157.x","article-title":"Substance P and alveolar macrophages: effects on oxidative metabolism and eicosanoid production","volume":"50","author":"Murris\u2010Espin","year":"1995","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.imlet.2020.11.009_bib0515","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1097\/ICO.0b013e31824d6ffd","article-title":"Substance P affects growth factors in pseudomonas aeruginosa-infected mouse cornea","volume":"31","author":"Foldenauer","year":"2012","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.imlet.2020.11.009_bib0520","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.4049\/jimmunol.1102147","article-title":"TRPV1 deletion enhances local inflammation and accelerates the onset of systemic inflammatory response syndrome","volume":"188","author":"Fernandes","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.imlet.2020.11.009_bib0525","article-title":"T cell substance P receptor governs antigen-elicited IFN-\u03b3 production","volume":"284","author":"Blum","year":"2003","journal-title":"Am. J. Physiol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0530","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4049\/jimmunol.157.1.255","article-title":"Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II","volume":"157","author":"Kincy-Cain","year":"1996","journal-title":"J. Immunol."},{"issue":"47","key":"10.1016\/j.imlet.2020.11.009_bib0535","doi-asserted-by":"crossref","first-page":"31427","DOI":"10.1074\/jbc.273.47.31427","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor \u03b1 transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein\/c-Jun","volume":"273","author":"Delgado","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.imlet.2020.11.009_bib0540","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.8.4685","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-\u03baB and IFN regulatory factor 1 activation","volume":"162","author":"Delgado","year":"1999","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0545","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-0115(97)01028-8","article-title":"Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets","volume":"72","author":"Xin","year":"1997","journal-title":"Regul. Pept."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0550","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.162.2.1200","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6","volume":"162","author":"Delgado","year":"1999","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0555","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.4049\/jimmunol.162.4.2358","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies","volume":"162","author":"Delgado","year":"1999","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0560","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2353\/ajpath.2008.070969","article-title":"Neuropeptides rescue mice from lethal sepsis by down-regulating secretion of the late-acting inflammatory mediator high mobility group box 1","volume":"172","author":"Chorny","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.imlet.2020.11.009_bib0565","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.exppara.2015.09.004","article-title":"Vasoactive intestinal peptide reduces the inflammatory profile in mice infected with Trypanosoma cruzi","volume":"159","author":"Higyno","year":"2015","journal-title":"Exp. Parasitol."},{"issue":"3-4","key":"10.1016\/j.imlet.2020.11.009_bib0570","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cyto.2006.11.005","article-title":"Vasoactive intestinal peptide (VIP) prevents killing of virulent and phoP mutant Salmonella typhimurium by inhibiting IFN-\u03b3 stimulated NADPH oxidative pathways in murine macrophages","volume":"36","author":"Foster","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.imlet.2020.11.009_bib0575","first-page":"665","volume":"Vol. 17","author":"Ebbo","year":"2017"},{"issue":"6383","key":"10.1016\/j.imlet.2020.11.009_bib0580","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.aap9598","article-title":"Neuronal-immune system cross-talk in homeostasis","volume":"359","author":"Veiga-Fernandes","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.imlet.2020.11.009_bib0585","first-page":"758","volume":"Vol. 17","author":"Spits","year":"2016"},{"key":"10.1016\/j.imlet.2020.11.009_bib0590","first-page":"111","volume":"Vol. 125","author":"Roediger","year":"2015"},{"key":"10.1016\/j.imlet.2020.11.009_bib0595","volume":"Vol. 11","author":"Domingues","year":"2020"},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0600","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0306-4522(87)90185-0","article-title":"Topographic localization of neuromedin u-like structures in the rat brain: an immunohistochemical study","volume":"23","author":"Honzawa","year":"1987","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0605","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0304-3959(03)00118-0","article-title":"A pro-nociceptive role of neuromedin U in adult mice","volume":"104","author":"Cao","year":"2003","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0610","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0306-4522(03)00300-2","article-title":"Pro-nociceptive effects of neuromedin U in rat","volume":"120","author":"Yu","year":"2003","journal-title":"Neuroscience"},{"issue":"7671","key":"10.1016\/j.imlet.2020.11.009_bib0615","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature23469","article-title":"Neuronal regulation of type 2 innate lymphoid cells via neuromedin U","volume":"549","author":"Cardoso","year":"2017","journal-title":"Nature"},{"issue":"7671","key":"10.1016\/j.imlet.2020.11.009_bib0620","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature23676","article-title":"The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation","volume":"549","author":"Klose","year":"2017","journal-title":"Nature"},{"issue":"6393","key":"10.1016\/j.imlet.2020.11.009_bib0625","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.09.004","article-title":"Transcriptional atlas of intestinal immune cells reveals that neuropeptide \u03b1-CGRP modulates group 2 innate lymphoid cell responses","volume":"51","author":"Xu","year":"2019","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2019.06.009","article-title":"Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation","volume":"51","author":"Nagashima","year":"2019","journal-title":"Immunity"},{"issue":"7470","key":"10.1016\/j.imlet.2020.11.009_bib0640","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature12526","article-title":"Type 2 innate lymphoid cells control eosinophil homeostasis","volume":"502","author":"Nussbaum","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.imlet.2020.11.009_bib0645","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.autneu.2014.01.006","article-title":"Autonomic regulation of cellular immune function","volume":"182","author":"Bellinger","year":"2014","journal-title":"Auton. Neurosci."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0650","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.smim.2014.01.003","article-title":"Neuroendocrine regulation of inflammation","volume":"26","author":"Padro","year":"2014","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0655","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4049\/jimmunol.136.1.152","article-title":"Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer\u2019s patches, mesenteric lymph nodes, and spleen","volume":"136","author":"Stanisz","year":"1986","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2020.11.009_bib0660","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI118944","article-title":"Vasoactive intestinal peptide induces S(alpha)\/S(mu) switch circular DNA in human B cells","volume":"98","author":"Fujieda","year":"1996","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0665","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbi.2007.08.013","article-title":"Morphological relationships between peptidergic nerve fibers and immunoglobulin A-producing lymphocytes in the mouse intestine","volume":"22","author":"Shibata","year":"2008","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0670","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12974-018-1145-1","article-title":"Neuropeptide regulation of adaptive immunity in the tibia fracture model of complex regional pain syndrome","volume":"15","author":"Li","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0675","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/IAI.73.1.317-324.2005","article-title":"Enhanced immunoglobulin A response and protection against Salmonella enterica serovar typhimurium in the absence of the substance P receptor","volume":"73","author":"Walters","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.imlet.2020.11.009_bib0680","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fimmu.2012.00146","article-title":"Role and relevance of mast cells in fungal infections","volume":"3","author":"Saluja","year":"2012","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0685","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002619","article-title":"The role of mast cells in the defence against pathogens","volume":"8","author":"Urb","year":"2012","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0690","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaci.2004.03.049","article-title":"Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3","volume":"114","author":"Kulka","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0695","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1182\/blood-2004-07-2656","article-title":"TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment","volume":"106","author":"Orinska","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.imlet.2020.11.009_bib0700","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev-immunol-042718-041812","article-title":"Neuro-immune cell units: a new paradigm in physiology","volume":"37","author":"Godinho-Silva","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.imlet.2020.11.009_bib0705","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI124609","article-title":"Neuro-immune crosstalk and allergic inflammation","volume":"130","author":"Kabata","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2020.11.009_bib0710","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000336523","article-title":"The mast cell-nerve functional unit: a key component of physiologic and pathophysiologic responses","volume":"98","author":"Forsythe","year":"2012","journal-title":"Chem. Immunol. Allergy"},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0715","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2340\/0001555561465469","article-title":"Electron microscopical evidence for a direct contact between nerve fibres and mast cells","volume":"61","author":"Wiesner-Menzel","year":"1981","journal-title":"Acta Derm. Venereol."},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0720","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.cell.2016.04.041","article-title":"Neuro-immune interactions at barrier surfaces","volume":"165","author":"Veiga-Fernandes","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0725","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tins.2018.09.006","article-title":"Mast cells in neuroimmune interactions","volume":"42","author":"Forsythe","year":"2019","journal-title":"Trends Neurosci."},{"issue":"12","key":"10.1016\/j.imlet.2020.11.009_bib0730","doi-asserted-by":"crossref","first-page":"29069","DOI":"10.3390\/ijms161226151","article-title":"Mast cell-mediated mechanisms of Nociception","volume":"16","author":"Aich","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0735","first-page":"65","article-title":"Significance of conversation between mast cells and nerves","volume":"1","author":"Kleij","year":"2005","journal-title":"Allergy Asthma Clin. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0740","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbadis.2011.03.019","article-title":"Relevance of mast cell-nerve interactions in intestinal nociception","volume":"1822","author":"van Diest","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"issue":"7\u20138","key":"10.1016\/j.imlet.2020.11.009_bib0745","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s004030050439","article-title":"Substance P- and antigen-induced release of leukotriene B4, prostaglandin D2 and histamine from guinea pig skin by different mechanisms in vitro","volume":"291","author":"Furutani","year":"1999","journal-title":"Arch. Dermatol. Res."},{"issue":"11","key":"10.1016\/j.imlet.2020.11.009_bib0750","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41590-019-0493-z","article-title":"House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation","volume":"20","author":"Serhan","year":"2019","journal-title":"Nat. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.imlet.2020.11.009_bib0755","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2009.12.006","article-title":"Substance P downregulates expression of the high affinity IgE receptor (FcepsilonRI) by human mast cells","volume":"220","author":"McCary","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0760","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1365-2567.2010.03296.x","article-title":"Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2","volume":"131","author":"Tancowny","year":"2010","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0765","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000236338","article-title":"Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo","volume":"99","author":"Dvorak","year":"1992","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0770","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jlb.49.2.197","article-title":"Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ","volume":"49","author":"Dvorak","year":"1991","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0775","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.peptides.2004.12.019","article-title":"Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson\u2019s disease model in rats: brain microdialysis, behavior, and microscopy","volume":"26","author":"Tuncel","year":"2005","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.imlet.2020.11.009_bib0780","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000384","article-title":"Influence of dendritic cells on viral pathogenicity","volume":"5","author":"Freer","year":"2009","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.imlet.2020.11.009_bib0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.06.022","article-title":"Cutaneous TRPV1(+) neurons trigger protective innate type 17 anticipatory immunity","volume":"178","author":"Cohen","year":"2019","journal-title":"Cell"},{"issue":"7503","key":"10.1016\/j.imlet.2020.11.009_bib0790","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature13199","article-title":"Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation","volume":"510","author":"Riol-Blanco","year":"2014","journal-title":"Nature"},{"issue":"38","key":"10.1016\/j.imlet.2020.11.009_bib0795","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1073\/pnas.0504484102","article-title":"Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders","volume":"102","author":"Chorny","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0800","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1189\/jlb.0605299","article-title":"Vasoactive intestinal peptide generates CD4+CD25+ regulatory T cells in vivo","volume":"78","author":"Delgado","year":"2005","journal-title":"J. Leukoc. Biol."},{"issue":"5","key":"10.1016\/j.imlet.2020.11.009_bib0805","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/mt.2009.293","article-title":"Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs","volume":"18","author":"Toscano","year":"2010","journal-title":"Mol. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2020.11.009_bib0810","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/cpdd.345","article-title":"Spotlight on Anti-CGRP monoclonal antibodies in migraine: the clinical evidence to date","volume":"6","author":"Pellesi","year":"2017","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"3","key":"10.1016\/j.imlet.2020.11.009_bib0815","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/WCO.0000000000000438","article-title":"Calcitonin gene-related peptide monoclonal antibodies for migraine prevention: comparisons across randomized controlled studies","volume":"30","author":"Mitsikostas","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"1","key":"10.1016\/j.imlet.2020.11.009_bib0820","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s10194-017-0807-1","article-title":"European Headache Federation School of Advanced, S., blocking CGRP in migraine patients - a review of pros and cons","volume":"18","author":"Deen","year":"2017","journal-title":"J. Headache Pain"},{"issue":"9","key":"10.1016\/j.imlet.2020.11.009_bib0825","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1177\/0333102416653233","article-title":"A phase IIb randomized, double-blind, placebo-controlled trial of ubrogepant for the acute treatment of migraine","volume":"36","author":"Voss","year":"2016","journal-title":"Cephalalgia"},{"issue":"19","key":"10.1016\/j.imlet.2020.11.009_bib0830","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.2019.16711","article-title":"Effect of Ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial","volume":"322","author":"Lipton","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0835","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1811090","article-title":"Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine","volume":"381","author":"Lipton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2020.11.009_bib0840","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.niox.2019.04.011","article-title":"Targeting nitric oxide as a key modulator of sepsis, arthritis and pain","volume":"89","author":"Spiller","year":"2019","journal-title":"Nitric Oxide"},{"issue":"2","key":"10.1016\/j.imlet.2020.11.009_bib0845","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4049\/jimmunol.1900818","article-title":"Unraveling the plastic peripheral neuroimmune interactome","volume":"204","author":"Jain","year":"2020","journal-title":"J. Immunol."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782030420X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782030420X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:38:19Z","timestamp":1759045099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524782030420X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":169,"alternative-id":["S016524782030420X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2020.11.009","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroimmune communication in infection and pain: Friends or foes?","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2020.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Immunological Societies. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}